← back to search

Jason L. Hornick

Dana-Farber Brigham Cancer Center · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, and Colorectal Cancer Treatments and Studies.
h-index
109
citations
43,750
works
1,078
NIH funding
primary concept
email

Recent publications

Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network 2025cited by 31position: middledoi
Clinician's primer for soft tissue sarcomas: Nuances of histologic subtypes
Cancer 2025cited by 8position: middledoi
Shifted assembly and function of mSWI/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas
Nature Genetics 2025cited by 2position: middledoi
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Annals of Surgical Oncology 2025cited by 1position: middledoi
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Annals of Surgical Oncology 2025cited by 0position: middledoi
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Annals of Surgical Oncology 2025cited by 0position: middledoi
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Journal of Clinical Oncology 2024cited by 37position: middledoi
<i>RAS/RAF</i> Comutation and <i>ERBB2</i> Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
Clinical Cancer Research 2024cited by 8position: middledoi
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation
Science Advances 2023cited by 56position: middledoi
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
Clinical Cancer Research 2023cited by 45position: middledoi
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors
Science Advances 2023cited by 31position: middledoi
What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?
Modern Pathology 2023cited by 13position: middledoi
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Endocrine Related Cancer 2022cited by 21position: middledoi
Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma
Histopathology 2022cited by 16position: middledoi
Spatially organized multicellular immune hubs in human colorectal cancer
Cell 2021cited by 794position: middledoi
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Journal of Thoracic Oncology 2021cited by 326position: middledoi
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Journal of Clinical Oncology 2021cited by 164position: middledoi
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
Blood 2021cited by 152position: middledoi
A standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop
American Journal of Obstetrics and Gynecology 2021cited by 72position: middledoi
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
Blood Advances 2021cited by 48position: middledoi
NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis
Modern Pathology 2021cited by 44position: middledoi
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas
Cancer 2021cited by 34position: middledoi
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19
Modern Pathology 2020cited by 305position: middledoi
The 2020 WHO Classification
The American Journal of Surgical Pathology 2020cited by 305position: lastdoi
The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research
Nature Medicine 2020cited by 270position: middledoi
A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma
The American Journal of Surgical Pathology 2020cited by 234position: lastdoi
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas
Annals of Oncology 2020cited by 150position: middledoi
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
Nature 2019cited by 258position: middledoi
Pan-TRK Immunohistochemistry
The American Journal of Surgical Pathology 2019cited by 68position: middledoi
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray
Laboratory Investigation 2019cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christopher D.�M. Fletcher · Harvard University7 papers (2012–2020)Alexander J. Lazar · Disco (Germany)5 papers (2012–2021)Lee D. Cranmer · City of Hope5 papers (2021–2025)Wei‐Lien Wang · The University of Texas MD Anderson Cancer Center5 papers (2012–2021) · 4 papers (2012–2018)Emily Z. Keung · The University of Texas MD Anderson Cancer Center3 papers (2025–2025)Inga‐Marie Schaefer · Harvard University3 papers (2015–2021)Lynette M. Sholl · Harvard University3 papers (2019–2021) · 3 papers (2025–2025) · 3 papers (2025–2025)Andrew J. Wagner · Dana-Farber Cancer Institute3 papers (2018–2024)Brian A. Van Tine · Jewish Hospital3 papers (2020–2024)David Gyorki · Peter MacCallum Cancer Centre3 papers (2025–2025)Michael J. Wagner · Dana-Farber Cancer Institute3 papers (2025–2025) · 3 papers (2025–2025) · 3 papers (2025–2025)Cigall Kadoch · Harvard University3 papers (2018–2025)Max Almond · University of Birmingham3 papers (2025–2025)Giovanni Grignani · Hospital Universitario Fundación Jiménez Díaz3 papers (2025–2025)Chandrajit P. Raut · Harvard University3 papers (2019–2025)